首页> 外文会议>Trends in Radiopharmaceuticals(ISTR-2005) >WHAT ROLE FOR ~(99m)Tc RADIOPHARMACEUTICALS IN THE AGE OF MOLECULAR IMAGING?
【24h】

WHAT ROLE FOR ~(99m)Tc RADIOPHARMACEUTICALS IN THE AGE OF MOLECULAR IMAGING?

机译:在分子成像时代,〜(99m)Tc放射性药物有何作用?

获取原文
获取外文期刊封面目录资料

摘要

Molecular imaging is a new paradigm that is currently emerging in the field of medical and biological sciences as a novel tool for exploring fundamental biological processes at the molecular level in integrated living organisms. Nuclear imaging is a sensitive methodological approach that employs radiolabelled probes to investigate biomolecular interactions. This approach may ultimately lead to a deeper understanding of the route through which single biochemical pathways are grouped to form networks of biological processes controlling the behaviour of a whole organism. Technetium-99m radiopharmaceuticals are playing an important role in this new scenario and are currently expanding the applications of these tracers, particularly through the use of high resolution small animal scanners. This review briefly illustrates some of the recent results in this area and the potential developments that may further stimulate the research interest in ~(99m)Tc imaging agents.
机译:分子成像是一种新的范式,目前正在医学和生物科学领域出现,作为探索综合生物体中的分子水平的基本生物过程的新型工具。核成像是一种敏感的方法方法,采用放射性标记的探针来研究生物分子相互作用。这种方法最终可能导致对单一生物化学途径被分组的途径更深入地理解,以形成控制整个生物体行为的生物过程网络。 Technetium-99M放射性药物在这一新场景中发挥着重要作用,目前正在扩大这些示踪剂的应用,特别是通过使用高分辨率小型动物扫描仪。本综述简要说明了该领域最近的一些结果和可能进一步刺激〜(99米)TC成像剂的研究兴趣的潜在发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号